Related Experiment Video
Updated: Mar 29, 2026

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
14.0K
Do All High- and Intermediate-Risk Patients With Metastatic Castration-Resistant Prostate Cancer Really Benefit From
1Bristol Cancer Institute, Bristol, United Kingdom Alfredo.Addeo@UHBristol.nhs.uk.
Abstract
No abstract available in PubMed .

